Averx Drugs Private Limited
About Averx Drugs Private Limited
Data last updated:
Averx Drugs Private Limited is a private limited company based in Paravada, Andhra Pradesh, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 26 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24100AP2014PTC095163. Its GSTIN is 37AAMCA8925H1Z9 (Andhra Pradesh).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.91 Cr. It is led by directors including Nagasekhar Ramineni (Managing Director) and Dhana Lakshmi Tirupathi.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Paravada, Andhra Pradesh.
As per the financials filed for FY 2021, the company reported a revenue of ₹6.36 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹68.2 Lakh (net margin -10.7%) and EBITDA of ₹48.54 Lakh (EBITDA margin 7.6%). Revenue has grown at a compounded annual rate (CAGR) of 170% over three years.
As per MCA filings, the company has open charges of ₹7.48 Cr on record. Court records list 7 cases involving the company, including 4 filed by the company and 3 filed against it; 4 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Averx Drugs Private Limited's registered office is in Paravada, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 27A 32A And 27A31 Denotified Area, Lalamkoduru Rambilli Atchuthapuram, Paravada, Andhra Pradesh, India – 531019
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Averx Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Averx Drugs Private Limited
FY 2021 filings availableAverx Drugs Private Limited reported revenue of ₹6.36 Cr (up 210% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 170% over three years, including 210% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹6.36 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹48.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹68.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | ||||
| Net Profit Margin | -10.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Averx Drugs Private Limited, buy the company report.
Board of directors of Averx Drugs Private Limited
Averx Drugs has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhana Lakshmi Tirupathi | Director | 25 Apr 2015 | 11 Years 6 Months | Current |
| Nagasekhar Ramineni | Managing Director | 27 Mar 2019 | 7 Years 7 Months | Current |
| Srinivas Ramineni | Additional Director | 29 Jan 2024 | 2 Years 9 Months | Current |
| Vns Gopal Raju Kurapati | Director | 26 Aug 2014 | 12 Years 2 Months | Current |
Auditor
Averx Drugs Private Limited is audited by RAVI SARMA & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVI SARMA & CO | FY 2021 | 015606S |
Shareholding
The shareholding of Averx Drugs Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Averx Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Sep 2018 | 100202612 | Others | ₹2.13 Cr | Open | |
| 31 Aug 2016 | 100047169 | Others | ₹5.35 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Averx Drugs Private Limited has 7 court cases on record: 4 filed by Averx Drugs, 3 filed against it. 4 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 1 | 2 |
| District courts | 2 | 1 | 2 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Court case (CRLP) | Filed by the company against The State of Andhra Pradesh | Pending |
| High Court of Andhra Pradesh | Court case (WP(PIL)) | Filed against the company | Pending |
| District court, Visakapatnam, Andhra Pradesh | Execution petition | Filed against the company by an individual | Pending |
| District court, East Godavari, Andhra Pradesh | Civil suit | Filed by the company against an individual | Pending |
| NCLT, Amravati | Company petition | Filed against the company by individuals | Disposed |
To see the full case history of Averx Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Averx Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Averx Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAMCA8925H1Z9 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Averx Drugs Private Limited, buy the company report.
Recent activity
Averx Drugs Private Limited has 9 board changes on record since 2014: 4 appointments and 5 cessations. The latest: Nagasekhar Ramineni ceased to be Director on 23 May 2024.
2 earlier events are in the company report.
Frequently asked questions
Averx Drugs is an active private limited company based in Paravada, Andhra Pradesh, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 26 August 2014 (12+ years old) and is registered under CIN U24100AP2014PTC095163.
Averx Drugs has 4 current directors:
- Nagasekhar Ramineni - Managing Director
- Dhana Lakshmi Tirupathi - Director
- Srinivas Ramineni - Additional Director
- Vns Gopal Raju Kurapati - Director
The latest financial statements of Averx Drugs on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Averx Drugs is 37AAMCA8925H1Z9, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Averx Drugs is U24100AP2014PTC095163. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Averx Drugs has 7 court cases on record: 4 filed by the company and 3 filed against it. 4 are pending. Most are in the high courts.
Averx Drugs was incorporated on 26 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Vijayawada.
Nagasekhar Ramineni ceased to be Director on 23 May 2024. Adilakshmi Nagireddy ceased to be Director on 27 Apr 2024. Srinivas Ramineni was appointed as Additional Director on 29 Jan 2024. Averx Drugs has 9 board changes on record in total.
The registered office of Averx Drugs is at Plot No 27A 32A And 27A31 Denotified Area, Lalamkoduru Rambilli Atchuthapuram, Paravada, Andhra Pradesh, India – 531019.
Averx Drugs operates in the pharma industry, in the animal pharmaceuticals and healthcare segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
